Ginkgo Bioworks Holdings GAAP EPS of -$1.08 beats by $2.24, revenue of $89.05M beats by $44.06M

seekingalpha
13 Nov 2024
  • Ginkgo Bioworks Holdings press release (NYSE:DNA): Q3 GAAP EPS of -$1.08 beats by $2.24.
  • Revenue of $89.05M (+60.7% Y/Y) beats by $44.06M.
  • Q4 Outlook: Ginkgo previously issued 2024 guidance for Total revenue of $170-190 million; Cell Engineering services revenue of $120-140 million; and Biosecurity

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10